Mental Health Clinics in Hewitt, NJ Accepting Medicare
4 Mental Health Clinics found. Showing 1 - 4
 Omega Wellness Llc Counselor Medicare: Not Enrolled in Medicare Practice Location: 81 Warwick Tpke, Hewitt, NJ 07421 Phone: 973-506-6645 |
Alpha Counseling Services, Llc Counselor Medicare: Not Enrolled in Medicare Practice Location: 81 Warwick Tpke, Hewitt, NJ 07421 Phone: 973-506-6645 |
Lynda R. Fabbo, Msw, Lcsw, Cht, Llc Community/Behavioral Health Agency Medicare: Medicare Enrolled Practice Location: 1954 Clinton Rd, Hewitt, NJ 07421 Phone: 201-341-4200 |
Hamsa House, Llc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 81 Warwick Tpke, Hewitt, NJ 07421 Phone: 973-506-6645 |
News Archive
Study reports high prevalence of vitamin D insufficiency in patients with psoriatic arthritis
New research reports a high prevalence of vitamin D insufficiency and deficiency among patients with psoriatic arthritis. Seasonal variation in vitamin D levels was not observed in patients in southern or northern locations.
Study offers new insights for vaccine development to prevent RSV disease
In healthy adults, RSV, or respiratory syncytial virus, feels like the common cold with a runny nose, chest congestion and cough.
Achieving AIDS-free generation worth more than Olympic gold
In this post in Huffington Post's "Healthy Living" blog, John-Manuel Andriote, a journalist and author living with HIV, asks, "For all of us living with HIV infection - Oct. 27 will mark seven years since my own diagnosis - the question we face daily, hopefully more consciously and deliberately than most, is how shall we live, knowing as we do that we will most assuredly die one day?"
Romney says he'll dismantle health law day 1 at the White House - will that help him win over the right?
On the Democratic side, Vice President Joe Biden takes on Romney, while news outlets offer fact checks and reports of health policy sparring on the congressional campaign trail.
Kiadis Pharma receives FDA approval for IND to start pivotal clinical study for ATIR
Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United States. Kiadis Pharma is currently enrolling patients in a multinational, pivotal clinical study at hospitals in Europe and Canada. With the approval of the IND, US hospitals will also participate in this study.
› Verified 7 days ago